7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
NANOCARRIERS FOR THE DELIVERY OF ANTIMICROBIAL AGENTS TO FIGHT RESISTANCE MECHANISMS (CycloN Hit)
Date du début: 1 mars 2014, Date de fin: 28 févr. 2018,
The worldwide spread of antibiotic-resistant microorganisms can be viewed as an ecological consequence of the systematic use of antimicrobial agents. Resistant bacteria prevail in healthcare environments where antibiotic selective pressure is intensive. Novel therapeutic approaches are urgently required to deliver the well-documented existing drugs in an optimized fashion to: i) protect them towar ...
Voir le projet
11
Participants partenaires
TERMINÉ
European Research Infrastructure on Highly Pathogenic Agents 2 (ERINHA2)
Date du début: 1 janv. 2016, Date de fin: 30 juin 2017,
ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administrative and technical maturity necessary to complete the establishment of the Research Infrastructre and ensure that the operation phase can begin in 2018. ERINHA2 will therefore finalise the decision to use the status of an association and prepare the necessary ...
Voir le projet
17
Participants partenaires
TERMINÉ
Exploring Chemical Biodiversity with Innovative Approaches for Fighting Chagas and Leismaniasis (CHEMBIOFIGHT)
Date du début: 1 avr. 2011, Date de fin: 31 mars 2015,
The ChemBioFight project aims towards the exploration of natural resources to the discovery of bioactive therapeutic molecules against leishmania and Chagas disease. This will be accomplished through the establishment of an extended scientific network between European and South American research entities. Already assembled, highly diverse chemical libraries will be employed for the determination o ...
Voir le projet
5
Participants partenaires
TERMINÉ
European Research Infrastructure on Highly Pathogenic Agents (ERINHA)
Date du début: 1 nov. 2010, Date de fin: 31 août 2014,
In the context of the emerging and re-emerging infectious diseases involving highly pathogenic microorganisms, European countries have to be well-prepared to face such threats. However, the Biosafety Level 4 (BSL4) capacity in Europe is not sufficient enough to cover the efficient development of diagnosis, prophylactic and therapeutics means against these pathogens. Moreover, there is no global co ...
Voir le projet
27
Participants partenaires
TERMINÉ
"Myasthenias, a group of immune mediated neurological diseases: from etiology to therapy." (FIGHT-MG)
Date du début: 1 déc. 2009, Date de fin: 31 mai 2014,
"Myasthenia Gravis (MG) is a heterogeneous rare autoimmune neurological disease affecting the neuromuscular junction (NMJ). The molecular events causing and maintaining MG are still unknown and current treatments do not lead to remission and entail considerable side-effects stressing the need for improved therapies. We will address the: 1. Natural course of disease: determine factors associated wi ...
Voir le projet
13
Participants partenaires
TERMINÉ
Development of a Center of Excellence in Neurosignalling (NeuroSign)
Date du début: 1 sept. 2010, Date de fin: 28 févr. 2014,
...uroSign is to create a national Centre of Excellence for the study of Neurosignalling during nervous system function and dysfunction, through capacity development of the neuroscience potential of the Hellenic Pasteur Institute. Our group integrates the activities of 18 researchers in topical issues ranging from the study of neuromuscular and neuroimmune interactions to neurodevelopment, stem cell ...
Voir le projet
1
Participant partenaire
TERMINÉ
Neurotransmitter Cys-loop receptors: structure, function and disease (NeuroCypres)
Date du début: 1 févr. 2008, Date de fin: 31 juil. 2012,
Cys-loop receptors (CLRs) form a superfamily of structurally related neurotransmitter-gated ion channels, comprising nicotinic acetylcholine, glycine, GABA-A/C and serotonin (5HT3) receptors, crucial to function of the peripheral and central nervous system. CLRs cover a wide spectrum of functions, ranging from muscle contraction to cognitive functions. CLR (mal)function is linked to various disord ...
Voir le projet